Richard Lentz, MD

8/6/2019 Richard Lentz, MD

1/15

SUMMARY OF EXPECTED TESTIMONY OFRICHARD LENTZ, M.D.Richard L entz, M.D . is a Board-certified clinical psychiatrist at Park Nicollet Clinic in theDepartment of M ental Health in M inneapolis, Minnesota. Dr. Lentz' educational backgroundand w ork experiences are described in his curriculum v itae, a copy of w hich is attached. Thetestimony and opinions of Dr. Lentz will be based upon his educational background, workexperiences, and his review of the depositions, documen ts, and medical records in this case. Dr.Lentz' opinions are expressed to a reasonable deg ree of m edical certainty. He reserves the rightto supplement his opinions if additional information becom es available.Dr. Lentz w ill testify that Stephen O lson, M.D.'s care and treatment of M r. Dan M arkingsonbetween Nov emb er 2003 and M ay 2004 m et the accepted standard of care for a doctor in asimilar practice under similar circum stances. He w ill explain that the care by D r. Olson w asreasonable and he w ill testify that Dr. Olson d id not cause injury to Mr. M arkingson.By way of background, Dr. Lentz will testify that Mr. Markingson was taken to Regions Hospitalon No vemb er 12, 2003, by the police after making threats about harming his m other, Ms. MaryW eiss. He was transferred to the University of M innesota M edical Center Fairview on thesame date and p laced under a 72-hour hold. Dr. Lentz will explain the meaning of such holds.Dr. Lentz w ill note that his treating psychiatrist was D r. Olson.Dr. Lentz will note that on Novemb er 13 M r. Markingson began taking Risperdal (0.5 mg perday), an anti-psychotic medication that can take effect within hours. Mr. M arkingson receivedother form s of treatment, including visits by Dr. Olson and others, as well as being in thestructured therapeutic environm ent of a hospital, where he remained un til December 8. O n thisdate Dr. Rodney M cFadden, an internal medicine specialist, evaluated him. An M RI scan of hisbrain was negative.Dr. Lentz w ill testify that on Nov ember 1 4, a Petition for Judicial Comm itment was filed, alongwith an Exam iner's Statement signed by Dr. Olson in which he recomm ended comm itment ofM r. Markingson as m entally ill because he lacked the capacity to make decisions regardingneuroleptic medications and did no t believe he had a m ental illness. Dr. Lentz will testify aboutthe comm itment process in Minnesota. Dr. Olson charted that M r. Markingson was compliantwith m edication. Mr. Markingson's dose of Risperdal was increased to 2 m g per day. There arenursing notes over the n ext several days that state that M r. Markingson un derstands the need totake m edication and stating that he no longer h ad hallucinations or d elusions. Dr. Lentz willtestify that these are positive developmen ts.Dr. Lentz will testify that on Novem ber 17, a Pre-Petition Screening Program Rep ort was filedwith the Dakota County court indicating that the screening team recommended the patient becomm itted as m entally ill. On this date, Dr. Olson's diagnosis was "Psychosis Not O therwiseSpecified." Dr. Lentz w ill testify that Dr. Olson charted that he "discussed with patient thediagnostic options of mood disorder versus schizophrenia-related disorder," and informed thepatient "that he should rem ain in treatment for at least 6 m onths to 1 year and then a decisionabout tapering medications could be considered."


2/15

Dr. Lentz will point out that on Novem ber 18 , Dr. Erin Holker performed a neuropsychologicalevaluation of Mr. Markingson and noted that he was no longer having strange thoughts and planson taking m edication. Moreover, he did not hav e cognitive deficits that might interfere in hisability to actively participate in his treatment. D r. Lentz will testify that evaluating a person'scapacity to make decisions involves consideration of cognition, negative symptoms, and positivesymptom s such as delusions and hallucinations, and this report indicates that he was com petentto make decisions.Dr. Lentz will testify about Dr. Olson's charting on Novem ber 18 rega rding a discussion withMr. Markingson about the Caf Study and that Mr. Markingson had reviewed writteninformation abou t the study. Dr. Lentz w ill testify that informed consent w ith respect to the CafStudy is a p rocess during which a potential participant in the study receives information aboutthe study and has an o pportunity to ask questions. Dr. Olson acted reasonably and appropriatelyby providing this opportunity to Mr. Markingson. Dr. Olson no tes Mr. Markingson's interest inthe study, an observation also charted by D r. Holker. Dr. H ans Jappeien sim ilarly charts adiscussion w ith Mr. Markingson ab out the study. Dr. Lentz will discuss the imp ortance of suchresearch for improving treatmen t of individuals with mental illness.Dr. Lentz will testify that the records reflect that on Novem ber 19, Jam es L. Jacobson, Ph.D.,L.P. examined M r. Markingson and issued a Report of Exam iner in wh ich he indicated thatalthough the patient had had "gross impainnent of judgm ent, behavior, capacity to recognizereality, capacity to reason or understand," during his interview on November 19 Mr. Markingsonwas: "fully oriented. His speech wa s clear. His thinking w as logical and goal directed. He d idnot appear to be delusional." He also noted that Mr. M arkingson had the capacity to take care ofhis own vital needs. Dr. Jacobson recommended "com mitment or a stay of comm itment," andindicated that the patient "should remain at the hospital, take his m edications, and await for adischarge from the hospital. He states he will cooperate w ith outpatient care." Dr. Lentz w illtestify that patients such as M r. Markingson may improve over the course of a few days in apsychiatric hospital in response to medications, to individual meetings w ith his psychiatrist andothers, to group therapies, to other interventions com mon to psychiatric inpatient settings, and tothe therapeutic structure of an inpatient environment.Dr. Lentz will note that on Novem ber 19, Dr. Olson "spent about 45 m inutes meeting w ithpatient's mother, and then patient together with her and K athleen Bernhoff to assess the patient'sprogress and plan his discharge. Probably will arrive at , a stay of com m itment wh en he has[court] hearing tomorrow. ... I explained about the CA FE Study and she w as interested. Thepatient continues to express interest after reviewing the m aterial I gave him y esterday. ... W illcontinue to screen him for the C A FE Study." Dr. Lentz w ill testify that Dr. Olson actedreasonably and appropriately in having additional discussions with Mr. Markingson a bout thestudy, giving him further opportunity to learn and ask questions about the study.Dr. Lentz will note that on Novem ber 20, Mr. Markingson made a court appearance in DakotaCounty and the court issued an Order of Com mitm ent to the Anoka M etro Regional TreatmentCenter, but stayed the imposition of that Order for 6 m onths on several conditions, including thatthe patient comply w ith medical treatment. Dr. Lentz w ill further testify that Dr. Olson saw M r.


3/15

Markingson later that day and increased the dose of Risperdal to 3 mg per day. Dr. Olson alsonoted that he talked to Mr. M arkingson about M s. Weiss ' concerns regarding the study.On November 21, Mr. Markingson consented to participate in the CAF Study. Dr. Olson andJeanne Kenney administered the consent form to Mr. Markingson. In addition, Jean Kenneyconducted an interview with him utilizing a competency form and signed the form as theevaluator. Elizabeth Lemke signed as a witness. Mr. Markingson then signed the informedconsent docum ent, with Jean Ken ney also signing it, with Dr. Olson signing as a witness.Dr. Lentz w ill testify that Mr. M arkingson w as an appropriate candidate to participate in the CafeStudy, including that he met the inclusion criteria. Dr. Lentz will also testify that Mr.Markingson received greater attention and care as part of the Caf Study than if he had notjoined the study.Dr. Lentz will testify that the question of competency is a separate issue from the presence ofmental illness. He will testify about the process of evaluating Mr. Markingson's competency tomake a decision about participating in the study. Dr. Lentz will testify that appropriate stepswere taken to assess his competency, including the use of questions contained on a formdeveloped for the Caf Study. Dr. Lentz will also testify that Mr. Markingson had consented totake medication while at the hospital, which supports the conclusion that he was competent. Dr.Lentz will testify that he disagees with the opinions of plaintiff s experts that Mr. Markingsonwas incapable of understanding the study. Dr. Lentz will testify about the patient's capacity tounderstand the study. Dr. Lentz will testify that patients with prominent positive symptoms,even w hen flagrantly psychotic, m ay have adequ ate cognitive function and decisional capacity tounderstand, appreciate, reason, and make appropriate voluntary choices about whether or not toparticipate in a research protocol. There is no accepted standard on how decisional capacityshould b e assessed in psycho tic patients in either research or clinical settings.Dr. Lentz will testify that he does not believe an independent physician, unrelated to the study,was required to evaluate the patient's competence. Dr. Lentz will testify that David Pettit, Mr.Markingson's Dakota County Case Manager, served as a neutral advocate for Mr. Markingsonand supported his participation because, among other things, it would provide more supervisionthan some of his other clients receive. Dr. Lentz will testify about the purpose of the questionson the form, and that it was reasonable and appropriate for Jean K enney to adm inister the form toMr. M arkingson.Dr. Lentz will testify that Dr. Olson's provision of informed consent to Mr. Markingson met anaccepted standard of care that a doctor in a similar practice would use under similarcircumstances, and that Dr. Olson did not cause injury to Mr. Markingson with respect to theinfoimed consent process. As noted above, Dr. Lentz will further testify that Dr. Olson was notrequired to seek an independent physician's assistance in providing informed consent to him.Dr. Lentz will testify that it is reasonable and appropriate to include a physician's own patients inresearch studies.Dr. Lentz will testify that Mr. Markingson was properly screened for the Cafe Study, includinguse of a screening evaluation completed by Jeanne Kenney on November 24, 2003. Dr. Lentz

3


4/15

will note that as part of the Caf Study, Mr. Markingson began to use one of three anti-psychoticmedications (Seroquel, Risperdal or Zyprexa) on December 5. In retrospect, it is known that Mr.Markingson was randomly assigned to take Seroquel. Dr. Lentz will testify about Seroquel, andits approval for certain psychiatric disorders, including schizophrenia. He will also testify aboutappropriate dosages of the medication and will testify that Mr. Markingson received appropriatedosages of the m edication during his participation in the Caf Study.Dr. Lentz will testify that Mr. Markingson moved into the Theodore House on December 8,2003, and stayed there until his death on May 8, 2004. Dr. Lentz will testify that the staff atTheodo re Hou se appropriately mo nitored him during his stay at the House, including charting hisstatus. He will testify that the staff appropriately monitored his medication usage, includingnoting an occasion on which he was suspected of cheeking his medication. Dr. Lentz will testifythat the staff responded appropriately to that incident by taking steps to more closely monitor hisconsumption of medication. Based upon the testimony and charting of the staff at TheodoreHo use, Mr. M arkingson did not exhibit behavior that constituted a threat to himself or others.Dr. Lentz will testify that Mr. Markingson participated in the Fairview outpatient Adult DayTreatment Program three days a week from mid-January 2004 until May 5, 2004. Dr. Lentz willtestify that the chart notes and deposition testimony do not indicate any behavior by Mr.M arkingson that constituted a threat to himself or others while in that program .Dr. Lentz will testify about Mr. Markingson's visits with Dr. Arlow Anderson, a psychologist atEagan Counseling Clinic. Mr. Markingson saw Dr. Anderson on five occasions from December2003 through April 2004. Dr. Lentz will testify that the charting and testimony of Dr. Andersondoes not indicate any basis for concluding that Mr. Markingson was a threat to himself or othersduring the foregoing time period.Dr. Lentz will note that Mr. Markingson met with Mr. Pettit on a regular basis from December2003 into May 2004. He will testify that the records and testimony of Mr. Pettit do not containany indication of a threat by Mr. Markingson to the safety of himself or others during theforegoing time period.Dr. Lentz will testify about Mr. Markingson's participation in the Caf Study, where he wasevaluated on eleven occasions: 4 times in December; 3 times in January; one time in February, 2times in March, and one time in April. Dr. Lentz will testify that he was seen by Dr. Olson,psychiatric social workers, and graduate students during these visits. Dr. Lentz will testify thatneither the study notes nor deposition testimony indicates that Mr. Markingson was a threat tohimself or others while in the study.Dr. Lentz will testify that the evidence does not suggest a deterioration of Mr. Markingson'smental health status between December 2003 and May 2004. He will explain that an isolated,unusual comment does not constitute deterioration of one's condition. He will explain that manyindividuals do not achieve complete resolution of psychotic symptoms, and that it is not unusualfor individuals with schizophrenia to occasionally or frequently make unusual comments. Dr.Lentz will also testify that Mr. Markingson was being observed by numerous individuals,including the staff at the Theodore House; staff at Fairview's day treatment program; Dr. Olson

4


5/15

and his staff as part of the Caf Study; his psychologist, Dr. Anderson; and David Pettit. He willexplain that their notes and testimon y do no t suggest that he w as a threat to himself or others.Dr. Lentz will testify that he disagrees with the opinions of plaintiff s experts that by March2004 it had become obvious that Mr. Markingson was not improving and was continuing todisplay severe psychotic symptom s. Dr. Lentz w ill also opine that there did not exist any reasonsto withdraw Mr. Markingson from the study. Mr. Markingson wanted to join and remain in thestudy, and he did not exhibit behavior that wou ld justify his rem oval from the study.Dr. Lentz w ill also testify about the decision to seek a continuation of the stay of comm itment forMr. Markingson. He will discuss a meeting that was held on April 9, 2004, involving Mr.Markingson, Dr. Olson, Mr. Pettit, Ms. Kenney, and Ms. Weiss, during which there was adiscussion about asking the court to extend the stay of commitment for an additional six months.Dr. Olson subsequently sent a letter in support of an extension. Dr. Lentz will testify that Dr.Olson acted reasonably and approp riately in this request based upon M s. W eiss ' concerns.Dr. Lentz will testify regarding Ms. Weiss' concerns about her son's participation in the studyand alleged deterioration of his condition. Dr. Lentz will testify that Ms. Weiss' complaints werenot specific or factual. Instead, she merely expressed frustration about her son's allegedlydeteriorating condition but did not identify a basis for her opinions. There was not sufficientevidence to commit him to a security hospital. For example, on April 11 (Easter Sunday), Mr.Markingson decided not to go to his mother's home for Easter. She became quite upset andtelephoned Jean Kenney and left a message stating, among other things, "Do we have to waituntil he kills himself or someone else before anyone does anything?" Dr. Lentz will testify thatthis complaint does not provide a substantive basis to alter Mr. Markingson's treatment, nor didother com plaints or comm ents by her provide a basis or justification for altering treatment.Dr. Lentz will also testify about Ms. Weiss' desire to become a conservator for Mr. Markingson.On ap proxim ately April 30, she comm unicated with M r. Pettit about this desire, including that shehad consulted a lawyer in that regard. Mr. Pettit informed the patient about this and the patientindicated he did not want his mother to become his conservator. Dr. Lentz will testify that therewere insufficient facts to support such an effort by M s. W eiss.Dr. Lentz will note that on May 4, a formal Petition for Extension of Stay of Commitment wasfiled with the court in Dakota County, and a hearing on that request was scheduled for May 14.Dr. Lentz will note that on May 5, Mr. Markingson completed the day treatment program atFairview an d was referred to Guild Em ploym ent Services for help in trying to find a job.Dr. Lentz will testify as to employment issues. Dr. Lentz will testify that Mr. Markingson wason public assistance, effective February 1, 2004. In addition, he was approved for SocialSecurity Disability in March 2004, with a retroactive date of December 17, 2003, for a paymentof $564.00 a month. Dr. Lentz will testify that schizophrenia is a life-long illness that affects aperson's ability to maintain employment. He will testify that even if Mr. Markingson was able toobtain gainful employment, it is likely that he would have experienced disruptions inemploym ent over the course of his working life.

5


6/15

o ary Public

vwwwwwwwsnAwnw.n.A.RJOEL J, CARLSON,

N O T A R Y P U B L I C -M I N N E S O T AMy CommMMori E x p i r e s J a n 3 t , 2 0 1 0vavvv;;;AAAAhvywAmAAAAAN~AnAN

Dr. Lentz will testify that Mr. Markingson unexpectedly committed suicide on the early morninghours of M ay 8, 2004, in a b athroom at Th eodore Hou se. Dr. Lentz will testify that the staff atTheodore, as well as other individuals invo lved in his care, have testified as to their shock at thesuicide of M r. Mark ingson. Dr. Len tz will testify that individuals with m ental illness canunexpectedly com mit suicide w ithout notice to anyone, as occurred here. Dr. Lentz will testifythat Mr. Markingson m ade a decision to comm it suicide and did not provide indications of hisintentions to others, based upon the records and testimony in this case. He will explain that theact of suicide does not mean that any care provider or other individual was neg ligent becausesuicide can occur unexpectedly and without warning, a 'n this case.i g cy:77RICHARD LENTZ:M.D.SUBSC RIBED and SWO RN to beforeme thisay of November, 20076


7/15

CURRICULUM VITAE S eptember 2007

R i chard D . L e ntz , M .S . , M .D .742 Dri l lane C ircleHopkins, M innesota 55305Personal Data

Date of BirthSpouseChildren

License and DEA

Professional Boards

Fellowship

Park Nicollet Clinic/Park Nicollet Health Services

January 27, 1942; P assaic, N ew JerseyJoan E . Lentz, P h.D. (P sychology)Daniel K. Lentz; December 6, 1989A ndrew S . Lentz; M ay 29, 1992M innesota 020575-3; N ovember 17, 1972D E A # A L 7 39 33 13A merican Boa rd of P sychiatry and N eurology (A dult P sychiatry),# 24776, A pri l 1983. Oral Examiner, 1990, 1994, 2005

Chief Proctor, written examination, 1991American Board of Pediatrics, # 18612. October 27, 1975P ediatr ic N ephrology S ubsection, American B oard ofP ediatrics, # 148, O ctober 9, 1976American Psychiatric AssociationFellow, 1990Distinguished Fellow, 2003

Mental HealthDepartmentActivities

Clinic and PNHSActivities

Consultant, M ental Health, 1981 -Vice Chair, M ental Health, 1984-9Co-Chair, Strategic Task Force, 1992-4L ong-R ange Planning C ommittee, 1990-2Interests: Complex diagnostic assessments; medicolegalevaluations; evaluation and treatment of physicians andother professionals; brain injury and epilepsy; currentoutpatient (and twenty years of inpatient) psychiatryP ersonnel C ommittee, 2003-R i sk M a n ag e m en t C o m m itte e , P N C a n d P N H SChair, 1995-99M ember, 1983-95P at ient R elat ions Department, P N C

Physician Director, 1983-96O perations C ommittee, 1992-4Innovator Aw ards, 1986, 1991Gold B eeper Award, 1992N IH Grant A pplication: E ff icacy of the Pe rsonal Health ImprovementP rogram and of M editation, 1996-8P ast Co mm ittees: P rofessional Growth and C ertif ication, S ervice-Quality T askForce, Quality A ssurance A dvisory B oard, Values C larif ication, Inter-doctorC ommunication, S enior Health Init iat ive, A d Hoc Disenrollment,Hospital R elations, N omination Co mmittee for O utstanding

1


8/15

C ommunity Service Aw ard, Development of P sychiatric Home C are,M editat ion R esearch Development Com mit tee, R ole ofA lternative M edicine in M ainstream Health C are.University oflinical Professor, P sychiatry, 1990-Minnesotalinical Associate Professor, Psychiatry, 1985-90

Clinical Assistant Professor, P sychiatry, 1981-5C linical Faculty A dvisory C ommittee, 1986-2000C linical S taff, U niversity of M innesota Hospitals, 1981-92C areer after residency, a panel discussion (organizer andmoderator), A dministrative P sychiatry C ourse, 1991-2000S mal l-Group L eader, P syche, course for second-year medicalstudents, 1993-Interests (P resent and P ast: C onsultation/Liaison P sychiatry; coordination ofpsychiatric services to pancreas transplantation patients; studyof psychiatric aspects of pancreas transplantation; traumaticbrain injury; teaching of fellows, residents, medical studentsProfessionalsychiatrist, 1992-9Assessmentssociate Director, 1993Programnterests: Asse ssmen t of physicians, dentists, nurses,psychologists, counselors, clergy, educators, attorneys,business executives, and others -- at the request of l icensingboards, impaired professional programs, institutions, clinics,groups, attorneys, or individualsHospital Affiliations A bbott-N orthwestern Hospital (R egular S taff)Chair, Psychiatry, 1991-2Vice Chair, Psychiatry, 1989-90P ast C ommit tees: P at ient Care, E mergency Room, S uicideP ol icy, M anagement Advisory, Physician C ustomer T eam,Program DevelopmentM ethodist Hospital (C ourtesy Staff)

P ast A ff il iat ions: U niversity of M innesota Hospitals (ClinicalS taff); Fairview S outhdale (C ourtesy Staff); M etropolitanM edical C enter (C ourtesy S taff )Professionalinnesota P sychiatr ic S ociety (M P S )Societiesoverning Council, 1987-90Chair, C ommit tee for B oard of M edical P ractice R elationships,1998-9Legislative Committee, 1987-2000

Chair and Organizer, T he Jarvis Symposium, A Quest forSolutions, September 24, 1988. (A working symposium oneffects of a M innesota S upreme C ourt commitmentdecision, sponsored by M P S , attended by representatives ofpsychiatric, judicial, legislative, advocacy, and other interests.Representative, B lue Cross and B lue S hield Advisory Board1987-90

Alternate Representative, Inter-specialty C ouncil of M innesotaM edical A ssociation, 1988-96Past Committees: Quality of C are, N ominatingAmerican Psychiatric AssociationM innesota M edical A ssociationGuaranteed Benefits Task Force, 1994P eer Support Panel, 1995-

2


9/15


10/15

Nephrology Resident, P ediatrics, U niversity of M innesota, July, 1970,to June, 1971Resident, N eurology and P ediatrics, WashingtonU niversity (S t. Louis), July, 1971, to June, 1972;Special Fellow, N ational Institutes of N eurologicalDiseases and S trokes, N ational Institutes of Health (N IH)Fellow, P ediatr ic N ephrology and R enal and P ediatr icP athology, U niversity of M innesota, July, 1972, to June,1973; Na tional Research Service Award, N IHFellow, P ediatric N ephrology, U niversity of M innesotaJuly, 1973, to June, 1974, and A ugust, 1976, to July,1978National Research Service Awards, N IHSumm er Fellow, Fellow, and Sum mer Extern, InN eurology and in C linical N europathology (SeeM edical and Graduate S chool)Research Training

Organicinetics of hydrolysis of tertiary phosphate esters.Chemistryreceptor: Robert T. Morrison, Ph.D. WashingtonS quare C ol lege, N ew Y ork U niversity. Summer Fellow,N ational S cience Foundation, 1963Biochemistry

ExperimentalNeuropathology

Isolation of postulated ganglioside receptor for serotoninfrom hog stomach. Preceptor: D.W. Wooley, Ph.D.,R ockefeller Un iversity. Summer Fellow, U ni ted StatesPublic Health Service, 1965

Tetraploid rat Purkinje cells. Preceptor: Lowell W.Lapham, M.D. University of Rochester School ofM edicine and D ent istry (S ee M edical and GraduateSchool)

Pediatricasic and Clinical Research. Preceptors: Robert F.Nephrologyernier, M .D., and Alfred F. M ichael, M.D. U niversityof M innesota M edical S chool (S ee C l in ical T raining,N eurology and P ediatric P athology)Medical andGraduate SchoolCollege

M.D. with Distinction in Research. U niversity of R ochesterS chool of M edicine and Dentistry, June, 1969M.S. Pathology (Neuropathology), U niversity of R ochesterS chool of M edicine and Dentistry, June, 1969. SummerFellow, U nited S tates P ublic Health Service, 1966, andFellow, U nited S tates P ubl ic Health S ervice, S eptember,1966, to A ugust, 1967Summer Extern, Hospital for N eurologic Diseases, QueenS quare, L ondon, England, 1968

B.S. Cum Laude, Washington S quare C ol lege, N ew Y orkU niversity, June, 1964Johns Hopkins U niversity, S eptember, 1959, to January,1961Master's Thesishe Tetraploid DNA Content of Rat Purkinje Cells. Universityof R ochester Sc hool of M edicine and Dentistry, 1969

4


11/15

Publications inRefereed Journals

1. Lentz RD, Lapham LW: A quantitative cytochemicalstudy of DNA content of rat cerebellar cortex. J. Neurochem16: 379, 19692. L entz R D, Lapham L W: P ostnatal development oftetraploid DN A content in rat Pu rkinje cells. E xptlN eurol 29: 43, 19703. L apham LW , Lentz RD , Woodward DJ, Hoffer BJ,Herman CJ: Postnatal development of tetraploid DNAcontent in the P urkinje neuron of the rat, an aspect ofcellular differentiation. In: Cellular Aspects of Neurol-Growth and Dif ferent iat ion, U C L A Forum in M edicalSciences, 14D. Pease (Ed.), U Calif Press, Berkely, 19764. Norby L, Lentz RD, Flamenbaum, Ramwell P: Prosta-glandins and aspirin therapy in Bartter's syndrome. Lancet2: 604, 19765. L entz R D, B ergstein J, S teffes M W, et a l: P ostpubertalE valuation of gonad al function following cyclophosp hamidetherapy before and during puberty. J. Ped iatr 91: 385, 19776. L entz R D, Brown DM , Kjel ls t rand C M : T reatment ofsevere hypophosphatemia. A nnals of Internal M edicine 89: 941,19787. L entz R D, M ichael A F, Friend P : M embranous t rans-formation lupus nephritis. Clin Immunol Immunopath 19:131, 19818. M i tch ell JE , Py l e R L , Eck ert E D, H at suk a m i D, Len tzR D: E lectrolyte and other physiological abnormalit ies inpatients with bulimia. Psycho log M ed 13: 273, 19839. P opki n M K, C a l li es AL , Len tz R D, C ol on E A ,S utherland DE : Prevalence of major depression, simplephobia and other psychiatric disorders in patients with long-standing type I diabetes mellitus. Arch Gen Psych 45: 64,198810. Lentz RD: Malpractice: Examining the presumptionof wrongdoing. Hosp and Commun Psych 40: 1074, 1989.(A lso reprinted in P hi Delta E psilon N ews and S cientif icJournal, 199011. L entz R D: When a de pressed patient fails to improve.P ostrad M ed 87: 251, 199012. Lentz RD: Disorders of depression (response to letterto editor). Postrad Med 87: 251, 199013. L entz R D: T reatment fa ilure in depression: Six comm onproblems. Depression B riefing 1: 36, 1991.14. P opki n M K, C a ll ies AL , C o lon E A , Len tz R D, Sut h erl an d

5


12/15

DE : P sychiatric diagnosis and the surgical outcome ofpancreas transplantation in patients with Type I diabetes mellitus.P sychosomatics 34: 251, 1993Presentations. P opkin M K, CaI l ies A L , Lentz R D, Bjerregaard W,(Refereed)utherland DE : Th e prevalence of major depressivedisorder in insulin-dependent diabetics. P oster, A nnualM eeting, Am erican P sychopathological A ssociation,N ew Y ork C i ty, February 28, 1985.

2. P opk in M K, C ol on E A , C a l li es AL , Len tz R D,S utherland DE : Psychiatric diagnosis and the outcomeof pancreas transplantation. Presentation, AnnualM eeting, Academy of P sychosomatic M edicine, L asVegas, O ctober 26, 1989Book Chapter

Other Publicationsand Presentations

L en tz R D, Popk in M K, C ol on EA , Sut h er la n d DE:P sychiatric aspects of pan creas transplantation. In:C raven JL, R odin G (eds.): Psychiatr ic A spects ofP ancreas T ransplantation. O xford U niversity P ress,1992I. Lentz RD: Psychiatric aspects of pancreastransplantation. Continuing Education (Nursing),U niversity of M innesota. M ay 2 and June 13, 19842. Lentz RD: Postpartum depression. InternationalC hildbirth E ducation A ssociation. M inneapolis,O ctober 4, 19853. L entz R D: P sychiatry for the ophthalmologist.Department of Ophthalmology, University ofMinnesota. April 4, 19864 . S w en son J S, B eecher L , Druck er J, F erron F ,Halikas J, Horton K, L entz R D, M anolis D, M itchell J:S tandards for quality psychiatric care, a position paper.M innesota P sychiatric S ociety, 1987.5. L entz R D: P ostpartum depression, current aspects.M ental health update for primary care physicians.Park Nicollet Medical Center. May 21, 19886. Lentz RD: How to talk to a psychiatrist. WellspringTherapeutic Community. Minneapolis. February 12,19907. L entz R D: M alpract ice: E xamining the presump-tion of wrongdoing. Minneapolis Academy ofM edicine. M inneapolis, February 19, 19908. L entz R D: E motional aspects of malpractice.T hird T hursday C l in ic M eeting, Park N icol let M edicalC enter, 19919. L entz R D: T he role of psychiatry in total brain

6


13/15

Injury and the treatment of agitation. P rofessionalP roviders R oundtable, M innesota Head Injury A ssocia-t ion. S eptember, 199110. L entz R D: S ession summaries, f rom the M aster 'sForum, m ult iple presentations at Pa rk N icollet C linicto B oard of Trustees, R egional Directors, and DivisionDirectors, 1991-211. L entz RD , Hari K, C raig J, Harvey P : P anel onstrategic marketplace issues. Mental Health DepartmentRetreat. Park Nicollet Medical Center, 199212. Lentz RD: When to refer to a psychiatrist. Abbot-N orthwestern Hospital, presented to clinical psycholo-gists and clinical social workers in the community.O ctober, 199313. L entz R D: P sychiatry and total brain injury. Headinjury family and friends education group, M innesotaHead Injury Association. November, 199314. P articipant, M odels of B oard P ersonalit ies,A "dramatic presentation" to the B oard of Directorsand the S trategic P lanning C ommit tee, T empleIsrael, M inneapolis, A ugust, 199315. L entz R D: T hird ring service enhancement andpatient complaints. Operations Committee, ParkN icol let M edical C enter, M arch 16, 199416. Hari K, Leach S , Lentz RD, M el l R : Return toFunction C onceptual, administrative and politicalIssues. Workshop in Third-Generation ManagedC are, Park N icollet M edical Foundation, A pri l 22, 199417. L entz RD , Greenwald S , Keul T : M edication issuesfor MI/CD patients (panel discussion). Kelly Programs,M inneapolis, M ay 6, 199418. L entz R D, S chaefer P: C ase Presentat ion,life-threatening picking and diabetes mellitus.C onsultation-L iaison Forum, Jan 12, 199519. L entz R D: T raumatic brain injuries and theWorkplace. St. Paul Rehabilitation Center, PackagingFirst, M arch 28, 199520. L entz R D: A ssessment of the brain-injured patient.A ssessment and R eferral S ervice, A bbott-N orthwesternHospital. December 2, 199721. Lentz RD: The impaired physician. Mental HealthU pdate,Park N icollet Institute, M arch 26, 200122. L entz RD : T he Disruptive P hysician, Presentation and Panel


14/15

Discussion, M innesota A ssoc. of M edical S taff S erv icesC onference, O ctober 29, 2004

Journal Reviewer

Consultant onNIH Grant

N ew E ngland Journal of M edicineA rchives of Internal M edicineA nnals of Internal M edicineInternational Journal of P sychiatry in M edicineS immons R G: S ocial-psychological studies in renaltransplant patients and donors, 1987

Recent Research. Lentz RD et al. Preparation of NIH grant: EfficacyActivitiesf the P ersonal Health Improveme nt P rogram in aM ulti-specialty clinic setting (quality of life, cost offsets,organizational issues, etc)2. L uepker E, M i li llo M , L entz R D: M ultid iscipl inarytherapeutic collaboration in the treatment of patientsabused by professional or clergy3. P sychiatric C onsultant, N IH E pilepsy grant

Management. To tal quality managem ent, Donald Berwick, M.D.Seminars Attendedanuary 10, 19912. Leadership for physician executives. LevinsonInstitute and Harvard M edical S chool, Novem ber 17-22,19913. M aster's Forum, a series of ten or m ore lecturesper year by leading business thinkers. C o-sponsoredby C arlson S chool of M anagement, U niversity ofM innesota, 1991-54. Roundtable Facilitator, M aster's Forum, 1992-35. S ervice organizations, W. E dwards Deming,M inneapolis, August 18-9, 19926. Workshop for outcomes assessment in musculo-skeletal disease (general review of issues in outcomesresearch). September 8, 19927. S ervice in Healthcare C ommunit ies, Irwin R ubin,M arch 17, 1994

Medicolegal Teaching 1. L entz R D: The medical expert witness (paneldiscussion). Harassment Claims, MinnesotaInstitute of Legal E ducation, M inneapolis, M arch 1,19952. Lentz RD: Preparation of the expert witness. Worked withtwo law students to prepare a videotaped expert witnessexamination for class discussion. Clifford Greene, Professor,William M itchell C ollege of L aw, 1998

8


15/15

3. L entz R D: T he Daubert decision and the expertwitness (panel discussion moderated by O gletree C J.)R esponsibil it ies and powers: T he Judge's role as gatekeeper.A nnual C onference of Judges, December 4, 1998, sponsored bythe M innesota S upreme C ourt.4. L entz R D: P sychiatric issues in traumatic brain injury.M innesota Institute of Legal E ducation, M inneapolis, O ctober 6,1999.5. L entz R D: P sychiatric issues in traumatic brain injury,presentation and panel discussion, M innesota T rial L awyersA ssociation, M inneapolis, M ay 5, 2006.

Richard Lentz, MD

Documents

Transcript of Richard Lentz, MD